Metacognition Assessment in Patient With Multiple Sclerosis (METACOGSEP)
Status
Conditions
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study will assessed the level of consciousness of MS patients suffering of cognitive and motor disorders. Understanding the awareness of the disease is crucial to allow better management of these patients. It has been shown, for other neurological pathologies, that a lack of awareness of deficits leads to inefficient rehabilitation and a disorder of understanding the impact of deficits in daily activities. Metacognition could be altered with age, so we will include participants between 18 and 60 years old.
Full description
Subject who have to do neurological assessement by the Multiple sclerosis Functional Composite (MSFC) will be enrolled.
The patient will estimate the time to undergo the test. This time will be compared to the time really make by the patient to realise test.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Diagnosis of multiple sclerosis
- Voluntary for participate to study
Exclusion criteria
- Neurological disease other than Multiple Sclerosis
- psychiatric disease, other than depressiveness
- illicit substance abuse
- Persons referred to in Articles L1121-5 to 8 of the French Public Health Code
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal